Chemcon Speciality Chemicals Ltd vs Saroja Pharma Industries India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 23, 2026

Key Highlights

The Latest Trading Price of Chemcon Speciality Chemicals Ltd is ₹ 140 as of 23 Mar 13:00 . The P/E Ratio of Chemcon Speciality Chemicals Ltd changed from 26.5 on March 2021 to 24.8 on March 2025 . This represents a CAGR of -1.32% over 5 yearsThe P/E Ratio of Saroja Pharma Industries India Ltd changed from 16.1 on March 2024 to 14.7 on March 2025 . This represents a CAGR of -4.45% over 2 years The Market Cap of Chemcon Speciality Chemicals Ltd changed from ₹ 1492 crore on March 2021 to ₹ 605.69 crore on March 2025 . This represents a CAGR of -16.51% over 5 yearsThe Market Cap of Saroja Pharma Industries India Ltd changed from ₹ 14.11 crore on March 2024 to ₹ 15.18 crore on March 2025 . This represents a CAGR of 3.72% over 2 years The revenue of Chemcon Speciality Chemicals Ltd for the Dec '25 is ₹ 60.96 crore as compare to the Sep '25 revenue of ₹ 57.66 crore. This represent the growth of 5.72% The revenue of Saroja Pharma Industries India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Chemcon Speciality Chemicals Ltd for the Dec '25 is ₹ 10.28 crore as compare to the Sep '25 ebitda of ₹ 10.8 crore. This represent the decline of -4.81% The ebitda of Saroja Pharma Industries India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Chemcon Speciality Chemicals Ltd changed from ₹ 5.37 crore to ₹ 5.09 crore over 7 quarters. This represents a CAGR of -3.01% The net profit of Saroja Pharma Industries India Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Chemcon Speciality Chemicals Ltd changed from 26.59 % on March 2023 to 0 % on March 2025 . This represents a CAGR of -100.00% over 3 yearsThe Dividend Payout of Saroja Pharma Industries India Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Chemcon Speciality Chemicals Ltd

Chemcon Speciality Chemicals Limited was formerly incorporated as a Private Company with the name 'Chemcon Speciality Chemicals Private Limited' in December 15, 1988 and later on, converted to a Public Company effective from 10th April 2019 in Ahemdabad, Gujarat.
The Company is into production of pharmaceutical intermediates, Silanes and Oilfield Chemicals (Completion Fluids) industry.
The Company is a leading manufacturer of specialized chemicals, such as Hexamethyldisilazane (HMDS) and Chloromethyl Isopropyl Carbonate (CMIC) which are predominantly used in the pharmaceuticals industry and inorganic bromides, predominantly used as completion fluids in the oilfield industry. Its manufacturing plant are located at Manjusar, Vadodara in Gujarat.
The Company is engaged in the business of manufacturing of speciality chemicals which are used in Pharmaceutical, Agro-Chemical, Engineering & Oilfield Chemicals (Completion Fluids) industries.

About Saroja Pharma Industries India Ltd

Saroja Pharma Industries India Ltd was originally incorporated as Private Limited, in the name and style of 'Saroja Pharma Industries India Private Limited' on January 14 , 2019 vide Certificate of Incorporation issued by the Registrar of Companies, Mumbai, Maharashtra.
Later on, Company was converted into Public Limited Company and due to conversion, name of the Company changed to 'Saroja Pharma Industries India Limited' through fresh Certificate of Incorporation dated April 18, 2023. Saroja Pharma Industries India Limited was founded in year, 2019 by Mr. Biju Gopinathan Nair and Mr. Manish Dasharath Kamble, upon becoming a globally integrated and highly regarded pharmaceutical and healthcare company, the two Promoters embarked on a journey to establish their business. In its initial stages, the Company operated as a Private Limited entity, operating with the name 'Saroja Pharma Industries India Private Limited.

FAQs for the comparison of Chemcon Speciality Chemicals Ltd and Saroja Pharma Industries India Ltd

Which company has a larger market capitalization, Chemcon Speciality Chemicals Ltd or Saroja Pharma Industries India Ltd?

Market cap of Chemcon Speciality Chemicals Ltd is 536 Cr while Market cap of Saroja Pharma Industries India Ltd is 11 Cr

What are the key factors driving the stock performance of Chemcon Speciality Chemicals Ltd and Saroja Pharma Industries India Ltd?

The stock performance of Chemcon Speciality Chemicals Ltd and Saroja Pharma Industries India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Chemcon Speciality Chemicals Ltd and Saroja Pharma Industries India Ltd?

As of March 23, 2026, the Chemcon Speciality Chemicals Ltd stock price is INR ₹146.5. On the other hand, Saroja Pharma Industries India Ltd stock price is INR ₹28.15.

How do dividend payouts of Chemcon Speciality Chemicals Ltd and Saroja Pharma Industries India Ltd compare?

To compare the dividend payouts of Chemcon Speciality Chemicals Ltd and Saroja Pharma Industries India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.